France· FR:61896847
MEBEVERINE ZENTIVA 200 mg, comprimé sécable
A mebeverine product containing chlorhydrate de mébévérine, registered in France by ZENTIVA FRANCE, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Mebeverine is registered in 13 of 19 countries.
Countries holding a registration under ATC A03AA04 (mebeverine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Mebeverine · ATC A03AA04
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of mebeverine costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.20 in France to $1.31 in Switzerland — a ×6.5 gap.
- France: $0.20 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Mebeverine · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.31
- FR France$0.20
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE MÉBÉVÉRINE
- Manufacturer
- ZENTIVA FRANCE
- Country
- France (FR)
- ATC code
- A03AA04
- ATC class
- Mebeverine
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400935072191plaquette(s) thermoformée(s) PVC-aluminium de 30 comprimé(s)EUR 2.65
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mebeverine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAurobeverine MR 200mg capsulesMilpharm Ltd
- PolandAuroverin MRAurovitas Pharma Polska Sp. z o.o.
- BelgiumDuspatalin 135 mgCooper Consumer Health
- NetherlandsDuspatal 135 mg, omhulde tablettenAbbott B.V.
- GermanyDuspatalViatris Healthcare Gmbh
- SpainDUSPATALIN 135 mg COMPRIMIDOS RECUBIERTOSViatris Healthcare Limited
- IrelandColofac 135 mg TabletsViatris Healthcare Limited
- SwitzerlandDuspatalin Retard
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Colofac, Colofac Retard
- Belgium · Duspatalin, Duspatalin Retard
- Bulgaria · Дуспаверин, Дуспаталин
- Cyprus · Medoverine, Spasverin
- Czechia · Duspatalin Retard
- Germany · Duspatal, Duspatal Retard
- Denmark · Duspatalin Retard
- Estonia · Mebeverine Sanoswiss
- Spain · Duspatalin, Mebeverina Tarbis
- United Kingdom (Northern Ireland) · Aurobeverine Mr, Boots Ibs Symptom Relief
- Greece · Duspatalin
- Croatia · Colospa Retard, Rudakol
- Ireland · Colofac, Mebeverine Hydrochloride Azure Pharmaceuticals
- Iceland · Duspatalin Retard
- Italy · Duspatal
- Lithuania · Duspatalin, Mebeverine Sanoswiss
- Luxembourg · Duspatalin, Duspatalin Retard
- Latvia · Duspatalin, Mebeverine Sanoswiss
- Malta · Colofac Retard, Mebeverine Hydrochloride Aspire Pharma (Malta)
- Netherlands · Duspatal, Duspatal Retard
- Poland · Auroverin Mr, Duspatalin Gastro
- Portugal · Duspatal Retard, Mebeverina Aristo
- Romania · Colospasmin, Duspatalin
- Slovenia · Rudakol
- Slovakia · Duspatalin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e257d45d-65be-48fd-bccf-845166e44de8 GET /v1/drugs/e257d45d-65be-48fd-bccf-845166e44de8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61896847",
"date_amm": "1999-04-08",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE DE MÉBÉVÉRINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about mebeverine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.